Safe discharge for patients admitted for lower gastrointestinal bleeding (LGITB): derivation and validation of a

Yue Zhao1, Madeline Yen Min Chee2, Rehena Sultana3

  • 1Ministry of Health Holdings, 110 Sengkang E Way, Singapore, 544886, Singapore. davidzhaoyue2003@gmail.com.

BMC Gastroenterology
|October 9, 2023
PubMed

Insights

A new clinical scoring system effectively predicts safe discharge for patients with lower gastrointestinal tract bleeding (LGITB). This tool aids in managing LGITB admissions and improving patient outcomes.

Area of Science:

  • Gastroenterology
  • Clinical Risk Assessment
  • Medical Informatics

Background:

  • Lower gastrointestinal tract bleeding (LGITB) is a frequent clinical concern.
  • Current guidelines advocate for clinical risk assessment tools in LGITB management.
  • Existing scoring systems for LGITB may require further validation or refinement.

Purpose of the Study:

  • To develop and validate a novel clinical scoring system for predicting safe discharge in patients admitted for LGITB.
  • To compare the performance of this new score against existing LGITB risk assessment tools.
  • To enhance clinical decision-making for LGITB patient disposition.

Main Methods:

  • Retrospective derivation cohort (n=798) and prospective validation cohort (n=312) of LGITB patients.
  • Multivariate binary logistic regression identified key predictors of safe discharge.
  • Area Under the Receiver Operating Characteristic Curve (AUROC) analysis compared scoring system performance.

Main Results:

  • Key predictors for safe discharge included: absence of prior LGITB, no ischemic heart disease, no rectal bleeding, no syncope/dizziness, and specific systolic blood pressure/hemoglobin levels.
  • The novel score achieved an AUROC of 0.907, demonstrating strong predictive power.
  • A cutoff of 4 yielded high specificity (97.5%) and positive predictive value (96.4%) for safe discharge prediction.

Conclusions:

  • The newly developed LGITB clinical risk score demonstrates robust predictive performance for safe patient discharge.
  • This novel score offers a valuable tool for clinicians managing LGITB admissions.
  • The score's performance is comparable to established tools like the Oakland score.
Abstract

Related Concept Videos

Assessment of the Gastrointestinal System I: Subjective Data01:17

Assessment of the Gastrointestinal System I: Subjective Data

Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
203
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
74
SBAR II: Application of SBAR01:14

SBAR II: Application of SBAR

SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
4.5K